Literature DB >> 22156144

Experience with a two-tier reflex gFOBT/FIT strategy in a national bowel screening programme.

Callum G Fraser1, Jayne Digby, Paula J McDonald, Judith A Strachan, Francis A Carey, Robert J C Steele.   

Abstract

OBJECTIVES: To evaluate a two-tier reflex guaiac-based faecal occult blood test (gFOBT)/faecal immunochemical test (FIT) algorithm in screening for colorectal cancer.
SETTING: Fourth screening round in NHS Tayside (Scotland).
METHODS: gFOBT were sent to 50-74-year-olds. Participants with five or six windows positive were offered colonoscopy. Participants with one to four windows positive were sent a FIT and, if positive, were offered colonoscopy. Participants providing an untestable gFOBT were sent a FIT and, if positive, were offered colonoscopy. Outcomes following positive results, cancer stages and key performance indicators were assessed.
RESULTS: Of 131,885 invited, 73,315 (55.6%) responded. There were 66,957 (91.3%) negative, 241 (0.3%) strong positive, 5230 (7.1%) weak positive and 887 (1.2%) untestable results. The 241 participants who had five or six windows positive had more cancers than those positive by other routes: only 3 of the 30 cancers (9.7%) were Dukes' A. Among the 983 positive results from the weak positive gFOBT then positive FIT route, there were fewer cancers and more normal colonoscopies, but more adenomas than in the group with a strong positive gFOBT. In those with an untestable gFOBT, 77 had a positive FIT result, with fewer true and more false positive results than in the other groups. Fewer males had cancer and stages were earlier than in females, but more had adenoma. The detection rate for cancer was 0.18% and the PPV for cancer and all adenomas was 41.3%.
CONCLUSIONS: The algorithm and FIT following a weak positive gFOBT have advantages. FIT following an untestable gFOBT warrants review.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22156144     DOI: 10.1258/jms.2011.011098

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  10 in total

1.  Normocytic anaemia is associated with systemic inflammation and poorer survival in patients with colorectal cancer treated with curative intent.

Authors:  Stephen T McSorley; Mark Johnstone; Colin W Steele; Campbell S D Roxburgh; Paul G Horgan; Donald C McMillan; David Mansouri
Journal:  Int J Colorectal Dis       Date:  2018-12-04       Impact factor: 2.571

2.  Interval cancers in a national colorectal cancer screening programme.

Authors:  Robert Jc Steele; Greig Stanners; Jaroslaw Lang; David H Brewster; Francis A Carey; Callum G Fraser
Journal:  United European Gastroenterol J       Date:  2016-01-06       Impact factor: 4.623

3.  The Relationship Between Co-morbidity, Screen-Detection and Outcome in Patients Undergoing Resection for Colorectal Cancer.

Authors:  Mark S Johnstone; Donald C McMillan; Paul G Horgan; David Mansouri
Journal:  World J Surg       Date:  2021-03-27       Impact factor: 3.352

4.  Temporal trends in mode, site and stage of presentation with the introduction of colorectal cancer screening: a decade of experience from the West of Scotland.

Authors:  D Mansouri; D C McMillan; C Crearie; D S Morrison; E M Crighton; P G Horgan
Journal:  Br J Cancer       Date:  2015-07-09       Impact factor: 7.640

5.  The impact of age, sex and socioeconomic deprivation on outcomes in a colorectal cancer screening programme.

Authors:  David Mansouri; Donald C McMillan; Yasmin Grant; Emilia M Crighton; Paul G Horgan
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

6.  The impact of aspirin, statins and ACE-inhibitors on the presentation of colorectal neoplasia in a colorectal cancer screening programme.

Authors:  D Mansouri; D C McMillan; C S D Roxburgh; E M Crighton; P G Horgan
Journal:  Br J Cancer       Date:  2013-06-18       Impact factor: 7.640

Review 7.  Advances in Fecal Occult Blood Tests: the FIT revolution.

Authors:  Graeme P Young; Erin L Symonds; James E Allison; Stephen R Cole; Callum G Fraser; Stephen P Halloran; Ernst J Kuipers; Helen E Seaman
Journal:  Dig Dis Sci       Date:  2014-12-10       Impact factor: 3.199

8.  Factors associated with completion of bowel cancer screening and the potential effects of simplifying the screening test algorithm.

Authors:  Benjamin Kearns; Sophie Whyte; Helen E Seaman; Julia Snowball; Stephen P Halloran; Piers Butler; Julietta Patnick; Claire Nickerson; Jim Chilcott
Journal:  Br J Cancer       Date:  2016-01-14       Impact factor: 7.640

9.  Variation in changes in the incidence of colorectal cancer by age and association with screening uptake: an observational study.

Authors:  Gavin Rc Clark; Annie S Anderson; Thomas G Godfrey; Judith A Strachan; Callum G Fraser; Robert Jc Steele
Journal:  BMJ Open       Date:  2020-09-22       Impact factor: 2.692

10.  Clinical outcomes using a faecal immunochemical test for haemoglobin as a first-line test in a national programme constrained by colonoscopy capacity.

Authors:  Robert Jc Steele; Paula J McDonald; Jayne Digby; Linda Brownlee; Judith A Strachan; Gillian Libby; Paula L McClements; Janice Birrell; Francis A Carey; Robert H Diament; Margaret Balsitis; Callum G Fraser
Journal:  United European Gastroenterol J       Date:  2013-06       Impact factor: 4.623

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.